Fujian Superpipe
300198
WuHan Hvsen Biotechnology
300871
Jiangsu LiXing General Steel Ball
300421
Telink Semiconductor(Shanghai)Co.,Ltd.
688591
Guangdong Kitech New Material Holding
300995
CN Stock MarketDetailed Quotes
600062 China Resources Double-Crane Pharmaceutical
- 18.84
- -0.03-0.16%
Trading Mar 26 09:52 CST
19.57BMarket Cap12.02P/E (TTM)
18.93High18.81Low17.79KlotVolume18.93Open18.87Pre Close33.55MTurnover0.17%Turnover Ratio12.02P/E (Static)1.04BShares26.0552wk High1.88P/B19.35BFloat Cap17.0952wk Low20.76Limit Up1.03BShs Float36.03Historical High16.98Limit Down0.64%Amplitude-1.85Historical Low0.36Dividend TTM18.86Avg Price9.77KlotAsk1.89%Div YieldTTM100Lot Size7.55KlotBid
China Resources Double-Crane Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.00%10.48B | -1.07%7.95B | -1.49%5.4B | 1.23%2.46B | 16.04%10.8B | 21.03%8.04B | 20.72%5.49B | 10.79%2.43B | 1.32%9.31B | -3.25%6.64B |
| Refunds of taxes and levies | -79.94%14.94M | -86.89%8.97M | -90.11%6.51M | -79.46%3.57M | -4.88%74.48M | 45.18%68.44M | 100.91%65.86M | -21.61%17.38M | 7.70%78.3M | -20.93%47.14M |
| Cash received relating to other operating activities | -8.81%139.95M | -26.23%84.56M | -13.62%61.65M | 93.76%22.56M | -10.22%153.47M | -7.25%114.61M | -9.40%71.36M | -63.61%11.64M | -16.03%170.93M | -41.11%123.58M |
| Cash inflows from operating activities | -3.60%10.64B | -2.13%8.04B | -2.68%5.47B | 1.09%2.48B | 15.40%11.03B | 20.69%8.22B | 20.78%5.62B | 9.41%2.46B | 0.99%9.56B | -4.51%6.81B |
| Goods services cash paid | -17.00%1.73B | -18.89%1.33B | -24.24%925.15M | -22.05%452.05M | -14.32%2.09B | -7.66%1.64B | -1.93%1.22B | -2.99%579.93M | -2.10%2.44B | -5.47%1.78B |
| Staff behalf paid | 5.06%2.5B | 5.57%1.93B | 5.96%1.35B | 7.19%715.98M | 21.79%2.38B | 26.91%1.82B | 30.29%1.27B | 13.75%667.93M | 6.98%1.95B | 3.18%1.44B |
| All taxes paid | -10.77%1.14B | -9.82%866.85M | -4.92%648.67M | 14.41%348.02M | 32.63%1.28B | 42.84%961.22M | 44.52%682.23M | 25.10%304.19M | 0.56%965.67M | -9.76%672.93M |
| Cash paid relating to other operating activities | 0.26%3.44B | -3.20%2.46B | -3.99%1.61B | -15.10%666.01M | 22.83%3.43B | 23.07%2.54B | 29.94%1.68B | 23.00%784.46M | -2.16%2.79B | -4.98%2.06B |
| Cash outflows from operating activities | -3.96%8.81B | -5.52%6.58B | -6.61%4.54B | -6.61%2.18B | 12.64%9.17B | 17.05%6.96B | 21.80%4.86B | 13.10%2.34B | 0.23%8.14B | -3.87%5.95B |
| Net cash flows from operating activities | -1.83%1.83B | 16.64%1.46B | 22.18%935.74M | 150.61%301.69M | 31.27%1.86B | 45.83%1.25B | 14.65%765.89M | -32.98%120.39M | 5.61%1.42B | -8.76%860.48M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -85.18%341.42M | -79.99%340.7M | -47.74%340.7M | 19.65%240.3M | -19.39%2.3B | -17.09%1.7B | -55.06%651.92M | -69.10%200.84M | -5.48%2.86B | 4.12%2.05B |
| Cash received from returns on investments | -66.35%27.03M | -64.92%27.03M | -57.96%27.03M | -12.00%1.46M | -15.30%80.3M | 81.50%77.05M | 672.92%64.28M | -59.46%1.66M | 224.59%94.81M | 167.46%42.45M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,605.61%57.1M | 4,153.33%55.93M | 7,804.22%52.83M | 1,785.31%1.73M | -14.41%3.35M | -59.22%1.32M | -76.04%668.43K | -50.63%91.87K | -65.72%3.91M | -69.84%3.23M |
| Cash received relating to other investing activities | 2,023.89%1.29B | --1.29B | 298.40%1.29B | ---- | 1,098.38%60.95M | ---- | 7,669.93%324.78M | ---- | -76.90%5.09M | -74.47%5.09M |
| Cash inflows from investing activities | -29.73%1.72B | -3.56%1.72B | 64.60%1.71B | 20.19%243.49M | -17.33%2.45B | -15.36%1.78B | -28.94%1.04B | -69.14%202.59M | -5.16%2.96B | 4.24%2.1B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 3.77%637.5M | 41.55%521.91M | -4.68%214.49M | 7.46%98.54M | 16.66%614.31M | -3.28%368.7M | -15.37%225.03M | -38.62%91.69M | 7.10%526.6M | 69.07%381.22M |
| Cash paid to acquire investments | -95.73%100M | -95.12%100M | -92.86%100M | -81.82%100M | 73.33%2.34B | 78.26%2.05B | 86.67%1.4B | -15.38%550M | -57.81%1.35B | -50.00%1.15B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --409.22M | --562.81M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | 234.84%276.64M | ---- | --164.66M | ---- | --82.62M | ---- |
| Cash outflows from investing activities | -77.17%737.5M | -74.29%621.91M | -82.43%314.49M | -69.06%198.54M | 36.42%3.23B | 15.50%2.42B | 76.17%1.79B | -19.73%641.69M | -35.84%2.37B | -17.08%2.09B |
| Net cash flows from investing activities | 225.41%982.46M | 271.93%1.1B | 287.16%1.4B | 110.24%44.95M | -232.26%-783.37M | -6,136.64%-637.45M | -266.21%-748.04M | -207.03%-439.11M | 203.94%592.28M | 102.09%10.56M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 7,555.11%1.15B | --640M | --140M | ---- | 935.54%15M | ---- | ---- | ---- | -69.47%1.45M | -37.84%1.45M |
| Cash received relating to other financing activities | --39.89M | ---- | ---- | ---- | ---- | 136.70%314.22M | ---- | ---- | --144.72M | --132.75M |
| Cash inflows from financing activities | 7,821.03%1.19B | 103.68%640M | --140M | ---- | -89.74%15M | 134.14%314.22M | ---- | ---- | 2,980.55%146.17M | 5,659.00%134.2M |
| Borrowing repayment | 3,283.67%230.97M | 4,397.96%222.47M | 5,823.51%211.11M | --2.26M | 10.21%6.83M | -20.14%4.95M | -42.46%3.56M | ---- | --6.19M | --6.19M |
| Dividend interest payment | 345.68%1.49B | 177.60%1.28B | 197.55%1.01B | 34.17%1.68M | -58.70%333.26M | 41.80%460.16M | 70.40%339.14M | 2,309.48%1.25M | 160.98%807M | 4.96%324.51M |
| -Including:Cash payments for dividends or profit to minority shareholders | -78.06%6.01M | -25.00%4.8M | -25.00%4.8M | ---- | 422.74%27.37M | 24.94%6.41M | --6.41M | ---- | -21.06%5.24M | --5.13M |
| Cash payments relating to other financing activities | 1,512.26%2.66B | 683.05%2.21B | 13,129.38%2.2B | -33.55%8.34M | -73.60%164.76M | -5.93%282.35M | -94.33%16.63M | -95.63%12.55M | 741.82%624.16M | 340.84%300.14M |
| Cash outflows from financing activities | 766.13%4.37B | 396.46%3.71B | 851.95%3.42B | -11.00%12.28M | -64.88%504.85M | 18.49%747.46M | -27.94%359.34M | -95.20%13.8M | 274.93%1.44B | 67.22%630.84M |
| Net cash flows from financing activities | -550.10%-3.18B | -608.80%-3.07B | -812.99%-3.28B | 11.00%-12.28M | 62.06%-489.85M | 12.77%-433.24M | 1.41%-359.34M | 91.00%-13.8M | -241.02%-1.29B | -32.46%-496.64M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 87.99%6.94M | -58.04%1.92M | -14.46%3.21M | 166.64%867.55K | -69.93%3.69M | -66.20%4.57M | -55.80%3.76M | 1.53%-1.3M | 843.45%12.28M | 273.60%13.52M |
| Net increase in cash and cash equivalents | -162.77%-370.03M | -369.87%-509.29M | -178.85%-941.76M | 200.42%335.23M | -19.19%589.53M | -51.35%188.72M | -144.32%-337.73M | -182.88%-333.82M | 85.26%729.55M | 492.78%387.92M |
| Add:Begin period cash and cash equivalents | 22.51%3.21B | 22.51%3.21B | 22.51%3.21B | 22.50%3.2B | 38.89%2.62B | 38.91%2.62B | 38.91%2.62B | 38.71%2.61B | 26.42%1.89B | 26.41%1.89B |
| Adjustment items for cash and cash equivalent increase | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| End period cash equivalent | -11.53%2.84B | -3.86%2.7B | -0.64%2.27B | 55.13%3.54B | 22.69%3.21B | 23.50%2.81B | -13.84%2.28B | 29.08%2.28B | 38.71%2.61B | 46.01%2.27B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
